Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index

被引:136
作者
Pang, Qing [1 ]
Zhang, Jing-Yao [1 ]
Song, Si-Dong [1 ]
Qu, Kai [1 ]
Xu, Xin-Sen [1 ]
Liu, Su-Shun [1 ]
Liu, Chang [1 ]
机构
[1] Xi An Jiao Tong Univ, Coll Med, Dept Hepatobiliary Surg, Affiliated Hosp 1, Xian 710061, Peoples R China
基金
中国国家自然科学基金;
关键词
Central obesity; General obesity; Nonalcoholic fatty liver disease; Body mass index; Waist circumference; INSULIN-RESISTANCE; METABOLIC SYNDROME; HEPATIC STEATOSIS; ALANINE AMINOTRANSFERASE; ANTHROPOMETRIC MEASURES; WAIST CIRCUMFERENCE; GENERAL-POPULATION; CENTRAL ADIPOSITY; HIGH PREVALENCE; ASSOCIATION;
D O I
10.3748/wjg.v21.i5.1650
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate whether central obesity is associated with nonalcoholic fatty liver disease (NAFLD) formation after adjusting for general obesity. METHODS: The online databases PubMed, EMBASE, and ISI Web of Science were searched for studies estimating the influence of central obesity on NAFLD occurrence published through April 2014. Studies that did not adjust for body mass index (BMI) were excluded. In addition, the independent effect of BMI was also assessed with the included studies. The pooled effect sizes and 95% confidence intervals (CIs) were calculated using random- or fixed-effects models based on the degree of heterogeneity. Furthermore, subgroup analyses, meta-regression, sensitivity analyses, and publication bias were performed. RESULTS: Twenty eligible studies were identified. The summary odds ratio (OR) values per-unit increase in waist circumference (WC) and BMI for NAFLD formation were 1.07 (95% CI: 1.03-1.10, I-2 = 73.9%, n = 11 studies) and 1.25 (95% CI: 1.13-1.38, I-2 = 88.7%, n = 11 studies), respectively. When the indices were expressed as binary variables (with the non-obesity group as reference), the pooled OR in WC, waist-to-hip ratio, and BMI were 2.34 (95% CI: 1.83-3.00, I-2 = 41.8%, n = 7 studies), 4.06 (95% CI: 1.53-10.79, I-2 = 65.7%, n = 3 studies), and 2.85 (95% CI: 1.60-5.08, I-2 = 57.8%, n = 5 studies), respectively. Using the same studies as the latter (n = 5), pooled OR in WC was 3.14 (95% CI: 2.07-4.77), which is greater than that in BMI. CONCLUSION: Central obesity may pose a greater threat to national health than general obesity, although both are independently associated with increased risk of NAFLD.
引用
收藏
页码:1650 / 1662
页数:13
相关论文
共 85 条
[1]   Nonalcoholic fatty liver disease [J].
Adams, LA ;
Angulo, P ;
Lindor, KD .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (07) :899-905
[2]   Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies [J].
Aune, D. ;
Greenwood, D. C. ;
Chan, D. S. M. ;
Vieira, R. ;
Vieira, A. R. ;
Rosenblatt, D. A. Navarro ;
Cade, J. E. ;
Burley, V. J. ;
Norat, T. .
ANNALS OF ONCOLOGY, 2012, 23 (04) :843-852
[3]   Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace [J].
Baffy, Gyoergy ;
Brunt, Elizabeth M. ;
Caldwell, Stephen H. .
JOURNAL OF HEPATOLOGY, 2012, 56 (06) :1384-1391
[4]   The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population [J].
Bedogni, Giorgio ;
Bellentani, Stefano ;
Miglioli, Lucia ;
Masutti, Flora ;
Passalacqua, Marilena ;
Castiglione, Anna ;
Tiribelli, Claudio .
BMC GASTROENTEROLOGY, 2006, 6 (1)
[5]   The role of TNF-α in insulin resistance [J].
Borst, SE .
ENDOCRINE, 2004, 23 (2-3) :177-182
[6]   The metabolic syndrome: common origins of a multifactorial disorder [J].
Bruce, K. D. ;
Byrne, C. D. .
POSTGRADUATE MEDICAL JOURNAL, 2009, 85 (1009) :614-621
[7]   Adiponectin, a key adipokine in obesity related liver diseases [J].
Buechler, Christa ;
Wanninger, Josef ;
Neumeier, Markus .
WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (23) :2801-2811
[8]   Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain [J].
Caballeria, Llorenc ;
Pera, Guillem ;
Antonia Auladell, Maria ;
Toran, Pere ;
Munoz, Laura ;
Miranda, Dolores ;
Aluma, Alba ;
Dario Casas, Jose ;
Sanchez, Carmen ;
Gil, Dolors ;
Auba, Josep ;
Tibau, Albert ;
Canut, Santiago ;
Bernad, Jesus ;
Maite Aizpurua, Miren .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 22 (01) :24-32
[9]  
Chalasani N, 2003, AM J GASTROENTEROL, V98, P2771, DOI [10.1016/j.amjgastroenterol.2003.09.037, 10.1111/j.1572-0241.2003.08767.x]
[10]   Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet [J].
Chan, Dick C. ;
Watts, Gerald F. ;
Gan, Seng Khee ;
Ooi, Esther M. M. ;
Barrett, P. Hugh R. .
DIABETES CARE, 2010, 33 (05) :1134-1139